The value of transesophageal echocardiography for embolic strokes of undetermined source
- PMID: 27488602
- PMCID: PMC5027807
- DOI: 10.1212/WNL.0000000000003063
The value of transesophageal echocardiography for embolic strokes of undetermined source
Abstract
Objective: Our aim was to evaluate the diagnostic yield of transesophageal echocardiography (TEE) in consecutive patients with ischemic stroke (IS) fulfilling the diagnostic criteria of embolic strokes of undetermined source (ESUS).
Methods: We prospectively evaluated consecutive patients with acute IS satisfying ESUS criteria who underwent in-hospital TEE examination in 3 tertiary care stroke centers during a 12-month period. We also performed a systematic review and meta-analysis estimating the cumulative effect of TEE findings on therapeutic management for secondary stroke prevention among different IS subgroups.
Results: We identified 61 patients with ESUS who underwent investigation with TEE (mean age 44 ± 12 years, 49% men, median NIH Stroke Scale score = 5 points [interquartile range: 3-8]). TEE revealed additional findings in 52% (95% confidence interval [CI]: 40%-65%) of the study population. TEE findings changed management (initiation of anticoagulation therapy, administration of IV antibiotic therapy, and patent foramen ovale closure) in 10 (16% [95% CI: 9%-28%]) patients. The pooled rate of reported anticoagulation therapy attributed to abnormal TEE findings among 3,562 acute IS patients included in the meta-analysis (12 studies) was 8.7% (95% CI: 7.3%-10.4%). In subgroup analysis, the rates of initiation of anticoagulation therapy on the basis of TEE investigation did not differ (p = 0.315) among patients with cryptogenic stroke (6.9% [95% CI: 4.9%-9.6%]), ESUS (8.1% [95% CI: 3.4%-18.1%]), and IS (9.4% [95% CI: 7.5%-11.8%]).
Conclusions: Abnormal TEE findings may decisively affect the selection of appropriate therapeutic strategy in approximately 1 of 7 patients with ESUS.
© 2016 American Academy of Neurology.
Figures
Comment in
-
Lumpers or splitters: Evaluation and management of embolic stroke of undetermined source.Neurology. 2016 Sep 6;87(10):972-3. doi: 10.1212/WNL.0000000000003072. Epub 2016 Aug 3. Neurology. 2016. PMID: 27488600 No abstract available.
References
-
- Manning WJ. Role of transesophageal echocardiography in the management of thromboembolic stroke. Am J Cardiol 1997;80:19D–28D. - PubMed
-
- Katsanos AH, Giannopoulos S, Frogoudaki A, et al. . The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis. Eur J Neurol 2016;23:569–579. - PubMed
-
- Hart RG, Diener HC, Coutts SB, et al. . Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014;13:429–438. - PubMed
-
- Alberts MJ, Latchaw RE, Selman WR, et al. . Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597–1616. - PubMed
-
- Adams HP Jr, Bendixen BH, Kappelle LJ, et al. . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical